NLRP3 and bacterial infectious disease: In addition, a pharmacological inhibitor, AC-YVAD-cho, which selectively inhibits the activation of Caspase-1, was used to reveal the role of NLRP3 inflammasome activation in protecting mice from bacterial infection.